Akito Oshima
Overview
Explore the profile of Akito Oshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oshima A, Higurashi M, Takase H, Asada K, Yamada S, Tateishi K, et al.
J Neurosurg
. 2024 Nov;
:1-9.
PMID: 39576985
Objective: The prognosis of isolated headache intracranial vertebral artery dissection (iVAD) without subarachnoid hemorrhage (SAH) or stroke is unknown. The authors of this study aimed to evaluate isolated headache iVAD...
2.
Motomura K, Sasaki K, Sugii N, Yamaguchi S, Inoue H, Oshima A, et al.
Jpn J Clin Oncol
. 2024 Sep;
54(10):1123-1131.
PMID: 39223700
Background: This study aimed to investigate what treatment are selected for malignant brain tumors, particularly glioblastoma (GBM) and primary central nervous system lymphoma (PCNSL), in real-world Japan and the costs...
3.
Tateishi K, Miyake Y, Nakamura T, Iwashita H, Hayashi T, Oshima A, et al.
Acta Neuropathol Commun
. 2023 Nov;
11(1):186.
PMID: 38012788
In IDH-mutant astrocytoma, IDH2 mutation is quite rare and biological mechanisms underlying tumor progression in IDH2-mutant astrocytoma remain elusive. Here, we report a unique case of IDH2 mutant astrocytoma, CNS...
4.
Hayashi T, Tateishi K, Matsuyama S, Iwashita H, Miyake Y, Oshima A, et al.
Clin Cancer Res
. 2023 Oct;
30(1):116-126.
PMID: 37851071
Purpose: The 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors uses an integrated approach involving histopathology and molecular profiling. Because majority of adult malignant brain tumors...
5.
Miyake Y, Tateishi K, Oshima A, Hongo T, Satomi K, Ichimura K, et al.
Neurooncol Adv
. 2023 May;
5(1):vdad043.
PMID: 37215953
No abstract available.
6.
Oshima A, Kimura T, Akabane A, Inoue T
Surg Neurol Int
. 2023 Jan;
13:574.
PMID: 36600775
Background: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies,...
7.
Noda R, Akabane A, Kawashima M, Oshima A, Tsunoda S, Segawa M, et al.
Neurosurg Rev
. 2022 Jul;
45(5):3457-3465.
PMID: 35834076
Tumor cyst aspiration followed by Gamma Knife radiosurgery (GKRS) for large cystic brain metastases is a reasonable and effective management strategy. However, even with aspiration, the target lesion tends to...
8.
Otomo Y, Ikegaya N, Oshima A, Matsumoto S, Udaka N, Chang C, et al.
Surg Neurol Int
. 2022 Mar;
12:631.
PMID: 35350828
Background: Intraventricular tumors can generally result in obstructive hydrocephalus as they grow. Rarely, however, some intraventricular tumors develop superficial siderosis (SS) and trigger hydrocephalus, even though the tumor has hardly...
9.
Sasame J, Ikegaya N, Kawazu M, Natsumeda M, Hayashi T, Isoda M, et al.
Clin Cancer Res
. 2022 Mar;
28(11):2425-2439.
PMID: 35344043
Purpose: Molecular targeted therapy using BRAF and/or MEK inhibitors has been applied to BRAFV600E-mutant high-grade gliomas (HGG); however, the therapeutic effect is limited by the emergence of drug resistance. Experimental...
10.
Oshima A, Sakata K, Ishikawa K, Manaka H, Kawasaki T
NMC Case Rep J
. 2022 Jan;
8(1):319-324.
PMID: 35079482
Background: Endodermal cyst (EC) is a rare congenital cyst of endodermal origin, but the pathogenesis of this entity remains uncertain. Supratentorial EC is particularly uncommon, but some cases have been...